2021
Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study
Ramsey CM, Lynch KG, Thase ME, Gelernter J, Kranzler HR, Pyne JM, Shih MC, Stone A, Committee C, Oslin DW. Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study. Journal Of Affective Disorders 2021, 282: 1272-1277. PMID: 33601706, DOI: 10.1016/j.jad.2021.01.034.Peer-Reviewed Original ResearchConceptsMajor depressive disorderMental Health Care studyGene-drug interactionsDepressive disorderPGx testingAD treatmentCare studiesHealth care studiesPrecision medicineContext of pharmacotherapyPrevalence of antidepressantsUtility of PGxPrescribing practicesUS veteransPharmacogenetic testingAntidepressantsPatientsPrevious treatmentPrevalenceTreatmentDisordersPGxMedicineTest panelParticipants
2014
DSM-5 Gambling Disorder: Prevalence and Characteristics in a Substance Use Disorder Sample
Rennert L, Denis C, Peer K, Lynch KG, Gelernter J, Kranzler HR. DSM-5 Gambling Disorder: Prevalence and Characteristics in a Substance Use Disorder Sample. Experimental And Clinical Psychopharmacology 2014, 22: 50-56. PMID: 24490711, PMCID: PMC4019046, DOI: 10.1037/a0034518.Peer-Reviewed Original ResearchConceptsSubstance Use Disorder SamplePathological gamblingGD diagnosisSemistructured psychiatric interviewFourth Edition diagnosisLogistic regression analysisGambling disorderDSM-5 diagnosisMultinomial logistic regression analysisDisorder sampleProspective studySUD sampleEdition diagnosisHigh prevalenceComorbid SUDPG criteriaPsychiatric interviewMental disordersDSM-IVSubstance dependenceDiagnosisPrevalenceStatistical ManualRegression analysisFifth edition